ESG

A new, independently validated study proves a curated digital health network can slash healthcare costs and improve outcomes, setting a new bar for ROI.

Beyond the ABCs, Sesame Workshop is expanding its global initiative to equip children and families with crucial tools for emotional well-being.

The prepared foods brand is launching in 2,750 stores, capitalizing on consumer demand for convenience and retailer needs for turnkey deli solutions.

A new testing platform from Armatus Bio aims to break a major bottleneck in gene therapy, promising faster paths to cures for rare neuromuscular diseases.

Standard skin checks often miss deadly melanomas. An Arizona dermatologist sounds the alarm on a critical detection gap and a tool that could save lives.

A new report shows CMOs wield unprecedented influence and AI, yet a majority feel their role is structurally flawed, hindering their path to success.

The clinical-stage biotech adds seasoned veterans from Eli Lilly and Iovance to accelerate its promising DNA Damage Response pipeline toward commercialization.

Valitor's VLTR-559 shows superior durability in preclinical data, potentially slashing wet AMD treatment from monthly injections to just two per year.

A landmark partnership between Propella Group and TISTR aims to unlock Thailand's hidden scientific gems, creating a pipeline for global VCs.

A new Incline Village store combines fire-retardant tech, construction, and lumber expertise to empower residents against the growing threat of wildfires.

Dr. Jerome Adams joins WellGenie, endorsing its zero-copay model and a bold pricing structure where half its fees are at risk. Can it fix healthcare?

As modern parents face record isolation, one early education brand is launching a new campaign to rebuild community, one school at a time.

An ultra-rare disease affects thousands, but few are diagnosed. Now, a new alliance of industry and advocates is racing to solve the diagnostic puzzle.

Omaha's Sequent Planning lands on USA TODAY's prestigious list of top advisors. Discover the blend of strategic growth and fiduciary care that fueled its rise.

With backing from Eli Lilly, Cabaletta Bio's $150M financing will accelerate its potentially curative cell therapies for autoimmune diseases.

Saudi-backed HUMAIN partners with AWS on HUMAIN ONE, an operating system for AI agents aiming to move businesses from pilots to production at scale.

With only 6% of sports science research focused on women, Gatorade's new 'Body of Science' initiative aims to finally close the critical knowledge gap.

GRIN Therapeutics expands its pivotal Phase 3 study for radiprodil to Europe, fueling hope for a first-ever targeted therapy for a rare neurological disorder.

Spanish CDMO ROIS acquires a major Phoenix facility from Bristol Myers Squibb, securing US drug supply chains and expanding its global footprint.

A Canadian firm reports major gold and copper finds in Bougainville, but its radical partnership model with local landowners may be the real discovery.